Discover how dopamine’s unexpected role in breaking down harmful plaques could revolutionize Alzheimer's treatment and ...

Researchers challenge everything we know about Alzheimer's disease with shocking new findings about amyloid beta protein's ...

Fenamate NSAIDs inhibit the NLRP3 inflammasome and 2 protect against Alzheimer’s disease in rodent models, published in the journal Nature Communications. DOI: 10.1038/NCOMMS12504 Please note, this ...

Alzheimer's leans to memory loss then progressive failure of mental and physical functions Early results in a new treatment for one of the most common forms of dementia have been "absolutely ...

(“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's disease ...

Once daily oral administration of blarcamesine meaningfully slowed clinical decline in early Alzheimer's disease ... a novel treatment that could be complementary or an alternative to injectable ...